{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:41:00Z","timestamp":1791409260243,"version":"4.3.3"},"reference-count":62,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Measles remains a major cause of morbidity and mortality among children in low- and middle-income countries (LMICs), despite widespread implementation of routine two-dose measles-containing vaccine (MCV) schedules. Serological assessment provides an objective measure of vaccine-induced immunity; however, evidence describing post-vaccination serological protection among children in LMICs remains fragmented and methodologically heterogeneous. Objective: To synthesize evidence on serological protection following routine two-dose MCV among children aged 1\u20135 years in LMICs and to identify determinants of immunity, methodological limitations, and evidence gaps relevant to immunization programmes. Methods: This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines and prospectively registered in PROSPERO (CRD420261300545). Literature searches were conducted in PubMed, MEDLINE, Scopus, Cochrane Library, CINAHL (EBSCO), and SciSpace on 21 January 2026. Two reviewers independently screened studies, extracted data, and assessed quality of evidence using Joanna Briggs Institute critical appraisal tools. Substantial clinical and methodological heterogeneity precluded meta-analysis; therefore, findings were synthesized narratively. Results: Eighteen studies met the eligibility. These studies were from 14 LMICs across four WHO regions (61.1% African Region, 27.8% Eastern Mediterranean Region, 5.6% each South-East Asia and the region of the Americas). Reported MCV seroprotection following completion of the two-dose schedule generally ranged from 30.6% to 100%, with the highest levels (87\u2013100%), but with evident lower protection in specific settings, such as rural Pakistan (30.6%) and Ethiopia (40\u201354%) despite having documented vaccination records. Lower protection was consistently associated with undernutrition, human immunodeficiency virus (HIV) infection, incomplete or delayed vaccination, younger age at first dose, and weak programme performance. Considerable variability was observed in study design, vaccination schedules, laboratory assays (ELISA, PRNT, haemagglutination inhibition, and others), seroprotective thresholds, timing of antibody assessment, and participant characteristics. Risk of bias was largely moderate-to-high, and certainty of evidence ranged from low to very low. Conclusions: Routine two-dose measles vaccination generally provides substantial serological protection among children aged 1\u20135 years in LMICs. Nevertheless, methodological heterogeneity and geographical evidence gaps limit direct comparisons and reduce confidence in cross-study interpretation. Greater standardization of serological assessment and thresholds, harmonized reporting methods, and well-designed longitudinal studies are needed to strengthen the evidence base and support immunization policies aimed at achieving and sustaining measles elimination.<\/jats:p>","DOI":"10.3390\/vaccines14090760","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:31:13Z","timestamp":1788251473000},"page":"760","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serological Protection After Routine Measles-Containing Vaccination Among Children Aged 1\u20135 Years in Low- and Middle-Income Countries: A Systematic Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0079-3330","authenticated-orcid":false,"given":"Imtiaz","family":"Hussain","sequence":"first","affiliation":[{"name":"School of Public Health, Health Services Academy, Islamabad 44000, Pakistan"},{"name":"Center of Excellence in Women and Child Health, Aga Khan University, Karachi 74800, Pakistan"},{"name":"Department of Paediatrics and Child Health, Aga Khan University, Karachi 74800, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2056-4132","authenticated-orcid":false,"given":"Babar Tasneem","family":"Shaikh","sequence":"additional","affiliation":[{"name":"School of Public Health, Health Services Academy, Islamabad 44000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0316-5672","authenticated-orcid":false,"given":"Haider","family":"Abbas","sequence":"additional","affiliation":[{"name":"School of Public Health, Health Services Academy, Islamabad 44000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3358-0705","authenticated-orcid":false,"given":"Ahmad","family":"Khan","sequence":"additional","affiliation":[{"name":"Center of Excellence in Women and Child Health, Aga Khan University, Karachi 74800, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4192-8406","authenticated-orcid":false,"given":"Sajid Bashir","family":"Soofi","sequence":"additional","affiliation":[{"name":"Center of Excellence in Women and Child Health, Aga Khan University, Karachi 74800, Pakistan"},{"name":"Department of Paediatrics and Child Health, Aga Khan University, Karachi 74800, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"Lancet"},{"key":"ref_2","unstructured":"WHO (2026, June 26). Measles and Rubella Strategic Framework: 2021\u20132030. Available online: https:\/\/www.who.int\/publications\/i\/item\/measles-and-rubella-strategic-framework-2021-2030."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/S1473-3099(17)30307-9","article-title":"The basic reproduction number (R(0)) of measles: A systematic review","volume":"17","author":"Guerra","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S420","DOI":"10.1093\/infdis\/jiaa793","article-title":"Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination","volume":"224","author":"Goodson","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.15585\/mmwr.mm7345a4","article-title":"Progress Toward Measles Elimination\u2014Worldwide, 2000\u20132023","volume":"73","author":"Minta","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_6","unstructured":"WHO (2026, March 10). Measles Cases Surge Worldwide, Infecting 10.3 Million People in 2023. Available online: https:\/\/www.who.int\/news\/item\/14-11-2024-measles-cases-surge-worldwide--infecting-10.3-million-people-in-2023."},{"key":"ref_7","unstructured":"Nicole, S.A. (2024). Addressing Gaps in Data and Methods in Measles Burden Estimation, London School of Hygiene & Tropical Medicine. Available online: https:\/\/researchonline.lshtm.ac.uk\/id\/eprint\/4672233\/."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Derqui, N., Blake, I.M., Gray, E.J., Cooper, L.V., Grassly, N.C., Pons-Salort, M., and Gaythorpe, K.A.M. (2024). Timeliness of 24 childhood immunisations and evolution of vaccination delay: Analysis of data from 54 low- and middle-income countries. PLoS Glob. Public Health, 4.","DOI":"10.1371\/journal.pgph.0003749"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e003515","DOI":"10.1136\/bmjgh-2020-003515","article-title":"Containing measles in conflict-driven humanitarian settings","volume":"5","author":"Scales","year":"2020","journal-title":"BMJ Glob. Health"},{"key":"ref_10","unstructured":"Gavi (2026, June 20). Zero-Dose Children and Missed Communities. Available online: https:\/\/www.gavi.org\/our-alliance\/strategy\/phase-5-2021-2025\/equity-goal\/zero-dose-children-missed-communities."},{"key":"ref_11","unstructured":"Cirone, N., Kalimeri, K., and Panciera, R. (2026, June 20). Reaching the Unreached with Life-Saving Vaccines Through Data Science and Geospatial Technologies. Available online: https:\/\/data.unicef.org\/wp-content\/uploads\/2025\/03\/RtU-technical-note_13Mar25.pdf."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.15585\/mmwr.mm6945a6","article-title":"Progress Toward Regional Measles Elimination\u2014Worldwide, 2000\u20132019","volume":"69","author":"Patel","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_13","unstructured":"Ilyas, F. (2026, June 20). Measles Claims Lives of 71 Children Across Country in Four Months, Dawn, Available online: https:\/\/www.dawn.com\/news\/1995081."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1016\/j.vaccine.2011.02.087","article-title":"Measles susceptibility in children in Karachi, Pakistan","volume":"29","author":"Sheikh","year":"2011","journal-title":"Vaccine"},{"key":"ref_15","unstructured":"(2026, July 10). WHO Measles\u2014Bangladesh. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2026-DON598."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"s819","DOI":"10.1136\/bmj.s819","article-title":"Measles Is Resurging in Bangladesh\u2014But This Outbreak Was Entirely Preventable","volume":"393","author":"Raqib","year":"2026","journal-title":"BMJ"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Plotkin, S.A., Orenstein, W.A., Offit, P.A., and Edwards, K.M. (2018). 37\u2014Measles Vaccines. Plotkin\u2019s Vaccines, Elsevier. [7th ed.].","DOI":"10.1097\/INF.0000000000002210"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Carazo, S., Billard, M.N., Boutin, A., and De Serres, G. (2020). Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: Systematic review and meta-analysis. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-4870-x"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S1473-3099(19)30395-0","article-title":"Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: A systematic review and meta-analysis","volume":"19","author":"Strebel","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Brady, A.M., El-Badry, E., Padron-Regalado, E., Escudero Gonz\u00e1lez, N.A., Joo, D.L., Rota, P.A., and Crooke, S.N. (2024). Serosurveillance for Measles and Rubella. Vaccines, 12.","DOI":"10.3390\/vaccines12070816"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1016\/j.vaccine.2018.04.036","article-title":"Assessing population immunity for measles elimination\u2014The promise and peril of serosurveys","volume":"36","author":"Durrheim","year":"2018","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1080\/21645515.2019.1616503","article-title":"Vaccination timeliness and delay in low- and middle-income countries: A systematic review of the literature, 2007\u20132017","volume":"15","author":"Masters","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: An underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"Cutts","year":"2016","journal-title":"Trop. Med. Int. Health"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e02716-20","DOI":"10.1128\/JCM.02716-20","article-title":"Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population Immunity","volume":"59","author":"Coughlin","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_25","unstructured":"WHO (2026, June 20). Immunization in Practice: A Guide for Health Workers. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240113275."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","article-title":"Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination","volume":"26","author":"Cohen","year":"2007","journal-title":"Vaccine"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lutz, C.S., Hasan, A.Z., Bolotin, S., Crowcroft, N.S., Cutts, F.T., Joh, E., Loisate, S., Moss, W.J., Osman, S., and Hayford, K. (2023). Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: A systematic review of head-to-head analyses of measles IgG EIA and PRNT. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08199-8"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: Reevaluation of protective titers","volume":"162","author":"Chen","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref_29","unstructured":"WHO (2026, June 18). Chapter 9: Manual for the Laboratory-Based Surveillance of Measles, Rubella, and Congenital Rubella Syndrome. Available online: https:\/\/www.who.int\/publications\/m\/item\/chapter-9-manual-for-the-laboratory-based-surveillance-of-measles-rubella-and-congenital-rubella-syndrome."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_31","unstructured":"Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., and Page, M.J. (2026, June 18). Cochrane Handbook for Systematic Reviews of Interventions Version 2024. Available online: www.cochrane.org\/handbook."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.11124\/JBIES-24-00103","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies","volume":"23","author":"Barker","year":"2025","journal-title":"JBI Evid. Synth."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.11124\/JBIES-22-00430","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid. Synth."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"378","DOI":"10.11124\/JBIES-23-00268","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies","volume":"22","author":"Barker","year":"2024","journal-title":"JBI Evid. Synth."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"833","DOI":"10.11124\/JBIES-24-00293","article-title":"Textual evidence systematic reviews series paper 3: Critical appraisal of evidence from narrative, opinion, and policy","volume":"23","author":"Barber","year":"2025","journal-title":"JBI Evid. Synth."},{"key":"ref_36","unstructured":"Goldkuhle, M., Kreuzberger, N., Neumann, I., Brennan, S., Meerpohl, J., Langendam, M., Davoli, M., Coello, P.A., Dahm, P., and Xia, J. (2026, July 06). Principles for Assessing the Certainty of Interventions. The GRADE Book 2024, 1.0. Available online: https:\/\/book.gradepro.org."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1016\/j.vaccine.2021.08.071","article-title":"Linked vaccination coverage surveys plus serosurveys among Ethiopian toddlers undertaken three years apart to compare coverage and serologic evidence of protection in districts implementing the RED-QI approach","volume":"39","author":"Campbell","year":"2021","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"126564","DOI":"10.1016\/j.vaccine.2024.126564","article-title":"Undernutrition and antibody response to measles, tetanus and Haemophilus Influenzae type b (Hib) vaccination in pre-school south African children: The VHEMBE birth cohort study","volume":"46","author":"Eskenazi","year":"2025","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1093\/infdis\/jir135","article-title":"Persistence of Vaccine-Induced Measles Antibody Beyond Age 12 Months: A Comparison of Response to One and Two Doses of Edmonston-Zagreb Measles Vaccine Among HIV-Infected and Uninfected Children in Malawi","volume":"204","author":"Fowlkes","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1086\/592756","article-title":"Evaluation of the Immune Response to a 2-Dose Measles Vaccination Schedule Administered at 6 and 9 Months of Age to HIV-Infected and HIV-Uninfected Children in Malawi","volume":"198","author":"Helfand","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_41","unstructured":"Kanga, A.J. (2021). Evaluation of Measles Immunity Among Children Aged 9 To 59 Months at Selected Health Facilities in Kwale, Narok, and Lamu Counties of Kenya, Jomo Kenyatta University of Agriculture and Technology."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1016\/j.vaccine.2013.08.044","article-title":"Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: A serological study within a randomised trial of different measles vaccines","volume":"31","author":"Martins","year":"2013","journal-title":"Vaccine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/jiu117","article-title":"Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age","volume":"210","author":"Martins","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Prosperi, C., Truelove, S., Carcelen, A.C., Chongwe, G., Mwansa, F.D., Ndubani, P., Simulundu, E., Bwalya, I.C., Hamahuwa, M., and Kapungu, K. (2025). High measles and rubella vaccine coverage and seroprevalence among Zambian children participating in a measles and rubella supplementary immunization activity. PLoS Glob. Public Health, 5.","DOI":"10.1371\/journal.pgph.0003209"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1128\/CVI.00183-13","article-title":"Effect of multivitamin supplementation on measles vaccine response among HIV-exposed uninfected Tanzanian infants","volume":"20","author":"Sudfeld","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_46","first-page":"4","article-title":"Measles Sero-Surveillance during Mass Immunisation Campaign in Malawi","volume":"78","author":"Takechi","year":"2001","journal-title":"E. Afr. Med. J."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Tejiokem, M.C., Desselas, E., Noumsi, T.J., Ateba Ndongo, F., Tetang Ndiang, S., Fossi, M.A., Guemkam, G., Zangue Kenfack Tekougang, B., Tagnouokam-Ngoupo, P.A., and Penda, I.C. (2025). Pre- and Post-Vaccination Measles Antibody and Persistence Up to 5 Years of Age Among Early ART-Treated HIV-Infected, HIV-Exposed Uninfected and HIV-Unexposed Children in Cameroon. Vaccines, 13.","DOI":"10.3390\/vaccines13060584"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4161\/hv.25993","article-title":"Immune response to 1 and 2 dose regimens of measles vaccine in Pakistani children","volume":"9","author":"Hussain","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.55627\/mic.003.001.0513","article-title":"Sero-Surveillance of Measles Virus Seropositivity Amongst Vaccinated Children of Rural Areas of Sindh, Pakistan","volume":"3","author":"Hussain","year":"2024","journal-title":"Microbiol. Immunol. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S0950268805004620","article-title":"Measles virus-specific antibody levels in Sudanese infants: A prospective study using filter-paper blood samples","volume":"134","author":"Ibrahim","year":"2006","journal-title":"Epidemiol. Infect."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.9734\/jpri\/2020\/v32i2730851","article-title":"Sero-conversion after Second Measles\u2019 Containing Vaccine in a Selected Sample of Young Children","volume":"32","author":"Karwi","year":"2020","journal-title":"J. Pharm. Res. Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/tropej\/fmq102","article-title":"Measles-mumps-rubella revaccination; 18 months vs. 4\u20136 years of age: Potential impacts of schedule changes","volume":"57","author":"Saffar","year":"2011","journal-title":"J. Trop. Pediatr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/ijmr.IJMR_4113_20","article-title":"Immunogenicity of measles-rubella vaccine administered under India\u2019s Universal Immunization Programme in the context of measles-rubella elimination goal: A longitudinal study","volume":"157","author":"Verma","year":"2023","journal-title":"Indian J. Med. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"17488","DOI":"10.1038\/s41598-020-73618-8","article-title":"Seroprevalence of measles antibodies and factors associated with susceptibility: A national survey in Mexico using a plaque reduction neutralization test","volume":"10","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.eclinm.2018.06.002","article-title":"Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-Analysis","volume":"1","author":"Mutsaerts","year":"2018","journal-title":"eClinicalMedicine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"20140141","DOI":"10.1098\/rstb.2014.0141","article-title":"Malnutrition and vaccination in developing countries","volume":"370","author":"Prendergast","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4103\/jfmpc.jfmpc_596_23","article-title":"Vaccine and malnutrition: A narrative review","volume":"12","author":"Tripathy","year":"2023","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1016\/j.vaccine.2016.06.006","article-title":"A review of testing used in seroprevalence studies on measles and rubella","volume":"34","author":"Dimech","year":"2016","journal-title":"Vaccine"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"100548","DOI":"10.1016\/j.jvacx.2024.100548","article-title":"Comparison of measles plaque reduction neutralization test (PRNT) and measles virus-specific IgG ELISA for assessment of immunogenicity of measles-mumps-rubella vaccination at 5\u20137 months of age and maternal measles antibodies","volume":"20","author":"Vittrup","year":"2024","journal-title":"Vaccine X"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/infdis\/jiz380","article-title":"What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic Review","volume":"221","author":"Bolotin","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"126908","DOI":"10.1016\/j.vaccine.2025.126908","article-title":"Investigating the measles susceptibility gap in Ontario infants","volume":"54","author":"Bolotin","year":"2025","journal-title":"Vaccine"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Ariyarajah, A., and Crowcroft, N.S. (2021). Measles Serosurveys: A Solution in Search of the Right Problem. Front. Public Health, 9.","DOI":"10.3389\/fpubh.2021.539325"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/760\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:44:31Z","timestamp":1788252271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":62,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vaccines14090760"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14090760","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}